Search Login Register

Extensively Drug-Resistant Tuberculosis Summary

30 relevant articles (0 outcomes, 0 trials/studies) found for this Disease

Description: Tuberculosis resistant to ISONIAZID and RIFAMPIN and at least three of the six main classes of second-line drugs (AMINOGLYCOSIDES; polypeptide agents; FLUOROQUINOLONES; THIOAMIDES; CYCLOSERINE; and PARA-AMINOSALICYLIC ACID) as defined by the CDC.

Also Known As: Extremely Drug-Resistant Tuberculosis; Tuberculosis, Extremely Drug-Resistant; XDR-TB; Drug-Resistant Tuberculoses, Extensively; Drug-Resistant Tuberculoses, Extremely Show All >>

Key Drugs and Agents for Extensively Drug-Resistant Tuberculosis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Rifampin (Rifampicin) : 10 results : FDA 10 Generic
  2. Isoniazid (Ftivazide) : 9 results : FDA 48 Generic
  3. Kanamycin : 8 results : FDA 21 Generic
  4. Capreomycin Sulfate (Capreomycin) : 7 results : FDA 1
  5. Amikacin (A.M.K) : 6 results : FDA 20 Generic
  6. Fluoroquinolones : 4 results : IBA
  7. Streptomycin (Streptomycin Sulfate) : 2 results : FDA 7
  8. Aminoglycosides : 2 results : IBA
  9. linezolid (Zyvox) : 2 results : FDA 4
  10. butyl 3-(1H-tetrazol-5-yl)oxanilate (MTB) : 2 results : IBA
Show All >>

Diseases Related to Extensively Drug-Resistant Tuberculosis

  1. Extensively Drug-Resistant Tuberculosis
  2. Tuberculosis
  3. Infection
  4. Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)

Key Therapies for Extensively Drug-Resistant Tuberculosis

Efficacy Chart >>
  1. Directly Observed Therapy : 3 results
  2. Therapeutics : 2 results
  3. Chemoprevention : 1 result
  4. Magic : 1 result
  5. Drug Therapy (Chemotherapy) : 1 result

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.